The Dexcom G7 is a real-time continuous glucose monitoring (rtCGM) system. It allows people living with diabetes to monitor their blood glucose levels around the clock without finger pricks. The system consists of two components:
With these tools, users receive real-time updates on their glucose levels, helping them make informed decisions about food, activity, and insulin use. This not only supports better day-to-day management but may also reduce the risk of complications over time.
The Ontario Drug Benefit Program is a provincial plan that helps eligible Ontarians pay for prescription medications and medical devices listed in the Ontario Drug Benefit Formulary. The program primarily serves people who are:
If you are part of any of these groups and are also living with diabetes and taking insulin, you are eligible to receive the Dexcom G7 system under this new coverage announcement.
This funding expansion means that thousands of Ontarians who previously could not afford CGMs may now get access to this advanced diabetes management technology.
To qualify for coverage under the ODB Program, you must meet the following criteria:
If you meet these conditions, you’re eligible to receive the sensors and receiver at no cost, aside from any applicable co-payments as set out by the ODB regulations.
The Ministry of Health will reimburse pharmacies for the cost of Dexcom G7 sensors and receivers. The payment structure includes:
Each person can receive up to 45 Dexcom G7 sensors per year, which aligns with their 10-day lifespan plus grace period.
This change is significant. For many people managing diabetes with insulin, CGMs have been out of reach due to cost. By including Dexcom G7 in the ODB program, Ontario is making it easier for eligible residents to access this life-changing technology.
Real-time data can help users catch highs and lows before they become dangerous, adjust medication and food intake more accurately, and live more confidently with diabetes. It also reduces the burden of routine fingerstick testing.
Navigating government programs and medical technology can be complicated. That’s where Endor Health comes in.
As a Canadian healthcare provider that specializes in diabetes support and device coordination, Endor Health helps patients and caregivers access the Dexcom G7 quickly and with confidence. If you’d like to order Dexcom G7 that is billed to ODB, you can:
By choosing Endor Health, you’ll get personalized help from professionals who understand the challenges of living with diabetes and are committed to making your experience simple and effective.
Ontario’s decision to fund Dexcom G7 CGM systems through the ODB Program is a big step forward for diabetes care. It means easier access, better tools for managing health, and fewer barriers for people who need real-time data to make life-saving decisions.
If you or a loved one qualifies for this new benefit, consider working with Endor Health to make the process smooth and supportive. Better diabetes care starts with the right tools—and now, they’re finally within reach for more Canadians.
